Chengdu Nuo´en Genomics Co., Ltd. announced that it has raised tens of millions of yuan in a round of funding led by new investor, Jiaxing Anhong Zhifei Venture Capital Partnership (Limited Partnership), on January 14, 2024. The transaction included participation from new investor, Tibet Rhodiola Pharmaceutical Holding Co..